Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Sweden.
Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Sweden
Eur J Prev Cardiol. 2016 Mar;23(4):420-7. doi: 10.1177/2047487315583798. Epub 2015 Apr 20.
We have shown that a case-based training programme for general practitioners, aimed to implement evidence-based care of patients at very high risk of coronary death, was associated with decreased mortality. In the present study we assessed long-term cost-effectiveness of this programme.
Registry-based long-term cost-effectiveness analysis on a clinical trial.
Costs of the programme, health care, drugs and added years of life were included. Costs were adjusted to 2012 level and discounted by 3%. Life-years gained were estimated as the difference between the survival curves of the trial. The effectiveness measure, quality adjusted life-years (QALYs), was constructed by multiplying each life-year with a quality of life weight corresponding to the health status of that year. QALYs were also discounted by 3%. Incremental cost-effectiveness ratio (ICER) was estimated as the incremental cost per QALY gained.
The number of undiscounted life-years gained was 365 days in the intervention group as compared to control (p = 0.02). The number of discounted QALYs gained was 0.66. The net increase in total costs was estimated as 17,862 € when costs of added years of life were included and 4621 € exclusive of these costs. This implied an ICER of 27,063 € per gained QALY. This ICER is well below commonly used threshold values of the societal willingness to pay for a QALY.
The results show that a case-based training programme of general practitioners is a cost-effective way to save years of life in patients with very high risk of coronary death.
我们已经表明,针对全科医生的基于案例的培训计划旨在为极有可能死于冠心病的患者实施基于证据的护理,可降低死亡率。在本研究中,我们评估了该计划的长期成本效益。
基于注册的临床试验长期成本效益分析。
包括计划成本、医疗保健费用、药物费用和增加的寿命年数。成本按 2012 年水平进行调整,并贴现 3%。生存曲线的差异用于估计获得的生存年数。通过将每年的生存质量乘以相应的健康状况的生存质量权重来构建有效度量指标,即质量调整生命年(QALY)。QALYs 也贴现 3%。增量成本效益比(ICER)是通过每增加一个 QALY 获得的增量成本来估计的。
与对照组相比,干预组未贴现的生存年数增加了 365 天(p=0.02)。贴现后的 QALY 数增加了 0.66。当包括增加的寿命年成本时,总费用的净增加额估计为 17862 欧元,而不包括这些成本时为 4621 欧元。这意味着每获得一个 QALY 的增量成本效益比为 27063 欧元。该 ICER 远低于社会对 QALY 的支付意愿的常用阈值。
结果表明,针对全科医生的基于案例的培训计划是一种节省极有可能死于冠心病风险患者生命年的具有成本效益的方法。